[HOMEに戻る]
全トライアル一覧2023.12.25現在 1321報
-
-
a
- ABCD
- ABCD (3)
- Abd El Aziz MS, et al.
- Abrahami D, et al.
- Abualsuod A, et al.
- ACC
- ACCOMPLISH (2)
- ACCORD (10)
- ACCORD BP (2)
- ACCORD BP HRQL substudy
- ACCORD Eye
- ACCORD HRQL
- ACCORD Lipid (3)
- ACCORD-MIND
- ACHOIS
- ACIP Database Study
- ACT NOW
- ACUITY
- AD-4833 Clamp-OGL Study
- ADAPT
- ADCT (2)
- ADDITION-Cambridge
- ADDITION-Europe
- ADDITION-Plus
- ADDITION-PRO
- Adeyemo MA, et al.
- ADMIT
- ADOPT (2)
- ADVANCE (9)
- ADVANCE-ON
- Agardh CD, et al.
- AgeCoDe study
- Ahmad J, et al.
- AKDN
- ALLHAT (3)
- ALSWH
- ALTITUDE (2)
- AMD-Annals Study
- AMPLITUDE-M
- AMPLITUDE-O
- Andersohn F.
- Andersson C.
- APOLLO
- ARIC (17)
- Arjona Ferreira JC, et al.
- ARTS
- ASCOT
- ASCOT-BPLA
- ASCOT-LLA
- ASIA study
- ASPEN
- AT.LANTUS (2)
- ATLANTIC DIP
- ATTEST
- AusDiab (4)
- AVOID
- AWARD (9)
- AWESOME
-
b
- Bain S, et al.
- Bangalore S, et al.
- Bannister CA, et al.
- BARI (4)
- BARI 2D (8)
- Barnett AH, et al.
- BEGIN FLEX
- BEGIN：ADD TO GLP-1 Study
- BENEDICT (3)
- Benelux-UK Insulin Lispro Study
- Berkowitz SA, et al.
- Bhattacharya R, et al.
- BIGPRO1
- Bionic Pancreas Research Group.
- BIP (2)
- BLSA
- BNP Multinational Study
- Bolinder J, et al.
- Botnia Study
- BRAVES
- British Regional Heart Study
- Britton KA.
- Brown SA, et al.
-
c
- C8 Health Project
- CABG Patch Trial
- CABRI
- CADILLAC
- CALDIRET
- CAMELLIA-TIMI 61
- CaMos
- Canadian-European Randomized Control Trial
- Candesartan in Diabetic Nephropathy Study
- CANTABILE
- CANTATA-D2 study
- CANTATA-SU
- CANVAS Program (4)
- Cao H, et al.
- CAPPP (3)
- CAPTIM
- CARDIA (4)
- CARDS (4)
- CARE
- CARMELINA
- Carnethon MR.
- Carter AA, et al.
- Casale Monferrato Study
- CASE-J
- CASS
- Caughey GE, et al.
- CCSPS
- CDC Diabetes Cost-effectiveness
- CDF
- CDQDPOS
- CDQDPS (2)
- Chakraborty A.
- Chan JC, et al.
- Chan SP and Colagiuri S
- Chang SH, et al.
- CHARM (4)
- Charpentier G, et al.
- Chatterjee S, et al.
- Cheng J, et al.
- CHICAGO
- Childhood Diabetes in Finland
- Chilton R, et al.
- Chronic Kidney Disease Prognosis Consortium
- CHS (3)
- Chung YR, et al.
- CIDES
- CLOuD
- CNHSS
- Coca SG, et al.
- Coleman KJ, et al.
- Collaborative Study (4)
- COMET
- CONCEPTT (1)
- CONTROL
- CORE
- CORONADO
- Corrao G, et al.
- COSMIC Approach Study
- CPS-II Nutrition Cohort
- CREDENCE (2)
- CREDIT
- Crump C, et al
- CTT
- CURES-2
- Currie CJ, et al. (2)
- CVD-REAL Nordic
- CVD-REAL Study
-
d
- Da Qing Diabetes Prevention Outcome Study
- DAFNE
- DAIS (4)
- DAISY
- DALI (3)
- DAMAD
- DANAMI-2
- DAPA-CKD (3)
- DAPA-HF
- Dapagliflozin 006 Study
- DAPIT (2)
- DARTS／MEMO (2)
- DAVID
- DCCT (14)
- DCCT／EDIC (17)
- DDCRT 18
- DDCRT 5
- De Cesaris R, et al.
- de Zeeuw D, et al.
- DECLARE-DIABETES
- DECLARE-TIMI 58 (4)
- DECODA (2)
- DECODE (5)
- DEPICT-1
- DEPICT-2
- DERI Mortality Study
- DERIS
- Derosa G, et al.
- DESIR
- DESMOND
- DETAIL
- Detemir in Pregnancy Study
- DEVOTE
- DHS
- DIA-AID 1
- DiabeDES
- DIABETES (2)
- Diabetes & Aging Study
- Diabetes and Aging Study
- Diabetes Surgery Study (2)
- Diabetic Ulcer Study
- DIABHYCAR (2)
- DIABIOPSIES
- DIABRASPORT
- DIACAN
- DIAD (3)
- DIAD-BAR Substudy
- Diamant M, et al.
- DIAMOND
- DIEP
- DIGAMI
- DIGAMI 2 (2)
- DIPOM
- DIRECT (3)
- DIRECT-Prevent 1／DIRECT-Protect 1
- DIRECT-Protect 2
- DIRECT-Renal
- DIS
- DiSC
- DIVINe
- Douros A, et al.
- DPP (23)
- DPPOS (3)
- DPS (5)
- DPT-1 (4)
- Draeger KE, et al.
- DREAM (4)
- Driessen JHM, et al.
- DUAL VI trial
- DURABLE
- DURATION-1
- DURATION-3
- DURATION-6
- DURATION-8
- Dutch and German Repaglinide Study
- Dutour A, et al.
- Foley JE, et al..
-
e
- ECASS-II
- EDC (2)
- EDIC (2)
- EDICTA
- EDIP (2)
- EDIT
- EDITION
- EDITION 2
- EDITION 4
- EDITION JP 1
- EHS-CR
- Eliasson B, et al.
- ELIXA
- Elleri D, et al
- Elliott RB, et al.
- ELSA-Brasil
- Emdin CA, et al.
- EMERALD
- Emerging Risk Factors Collaboration (2)
- EMPA-KIDNEY
- EMPA-REG BP
- EMPA-REG METSU trial
- EMPA-REG OUTCOME (4)
- EMPEROR-Reduced (2)
- EMPEROR-Reduced/DAPA-HF
- EMPIRE
- EMPULSE
- ENDIT (2)
- EPIC
- Epic-InterAct (2)
- EPIC-Postdam
- EPOCH
- Eppenga WL, et al.
- Eriksson JW, et al.
- Erqou S, et al.
- ESC-HFA Heart Failure Long-Term Registry
- Esposito K, et al.
- ESPRIT (2)
- ETDRS (9)
- EUCLID (3)
- Eurich DT, et al.
- EURODIAB IDDM Complications Study
- EURODIAB Prospective Complications Study (7)
- European Insulin Glargine Study
- European Microalbuminuria Captopril Study
- EXAMINE (3)
- EXSCEL
- ExTRACT-TIMI 25
-
-
f
- FACET
- Fagot JP, et al.
- FDS
- FDS1
- Ferrannini E, et al.
- FIDELIO-DKD (3)
- FIELD (7)
- FIGARO-DKD (2)
- FinnDiane (11)
- Finne P, et al.
- FINRISK and DPS
- FIT
- FLAT-SUGAR trial
- Foghsgaard S, et al.
- Forbes A, et al.
- Four Nations Diabetic Retinopathy Screening Study
- Framingham Heart Study (5)
- Framingham Offspring Study (5)
- Framingham Study (2)
- Frandsen CS, et al.
- Fraser W Gibb, et al
- FREEDOM
- Fukuoka Diabetes Registry
- Fulcher GR, et al.
- Funagata study (4)
-
g
- Gallwitz B, et al.
- Gallwitz B.
- Garber AJ, et al.
- GEMINI (3)
- German Diabetes and Dialysis Study
- German Humalog-CSII Study
- GISSI-3
- GISSI-Prevenzione Trial
- Giugliano D, et al.
- GLAL
- Glimepiride Combination
- Glimepiride Protocol #201 Study
- Gokhale M, et al.
- Gómez-Ambrosi J, et al.
- Gordon J, et al.
- Goto A, et al.
- GRADE (2)
- GREACE
- Guest JF, et al.
- Guo X, et al.
- GUSTO
- GUSTO V
- GUSTO-I
- GUSTO-IIb Angioplasty Substudy
- GWAA
-
h
- HAAS
- Hamada S and Gulliford MC.
- Haneda M, et al.
- HAPO
- HAPO FUS
- Hariyanto TI, et al.
- Harrison LB, et al.
- Health 2000 Health Examination Survey/Health 2011 study
- Health Economics Research
- Health Professionals Follow-up Study
- Heart and Soul Study
- HEART2D
- Heerspink HJL, et al.
- Helsinki Heart Study
- Hermann LS, et al.
- Hermida RC, et al.
- Hero C, et al.
- Hippisley-Cox J, et al.
- Hirsch IB, et al.
- Hisayama study (8)
- HOE 901 (3)
- HOME (2)
- Honolulu Heart Program (4)
- Hoorn Study (3)
- HOPE (5)
- HOPE-TOO
- Horie I, et al.
- HOT
- HPFS
- Hsu PF, et al.
- Hu Y, et al.
- Huang CC, et al.
- Huxley RR, et al.
- HypoCOMPaSS
-
i
- IDES_2
- IDNT (5)
- Idorn T, et al.
- IDPP
- IDPP-1
- ILLUMINATE
- IMPACT
- IMPERIUM
- Inaba M, et al.
- Inagaki N, et al. (2)
- Indianapolis-Ibadan Dementia Project
- INNOVATION (2)
- INSIGHT (2)
- Insulin Glargine in Type 1 Diabetes
- inTandem3 trial
- INTERVAL
- Inukai K, et al.
- INVEST (2)
- IOLITE
- Iowa Women's Health Study
- IRAS (5)
- IRMA2
- ISAR-DIABETES
- ISAR-SMART
- ISAR-SWEET
- ISIC
- Italian Microalbuminuria Study
- Italian Multicenter Lispro Study
- Ito D, et al.
- Iwamoto J, et al.
- Iwao T, et al.
-
j
- J-DOIT3
- J-LIT
- J-MIND
- J-STEP/INS
- James C, et al.
- Janghorbani M, et al.
- Japan CDM
- JAPAN-IDDM
- Japanese American Community Diabetes Study (2)
- Japanese-Brazilian Diabetes Study
- Jayedi A, et al.
- JDCS (10)
- JDCS/J-EDIT
- JDDM 11
- JDDM36
- JGSG
- Ji L, et al.
- Jin SM, et al.
- JMIC-B
- JMS Cohort Study
- Johnson JA. (2)
- Joslin Proteinuria Cohort study
- JPAD (3)
- JPHC (3)
- JUPITER
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study (2)
-
k
- Kadowaki T, et al. (3)
- Kahkoska AR, et al.
- Kahleova H, et al.
- Kaku K, et al. (1)
- Kansai Healthcare Study (3)
- Karagiannis T, et al.
- Kashiwa Study
- Kautzky-Willer A, et al.
- Kawamori R, et al. (2)
- Khan TA, et al.
- Khunti K, et al.
- Kitwitee P, et al.
- Klein BE, et al.
- KLIS
- KNDP
- Kodama S, et al.
- KoGES
- Kohan DE, et al.
- KOPS
- KPNC
- Kramer CK, et al. (2)
- Kumamoto study (3)
- Kuo HK, et al.
- Kuusisto J, et al.
- Kwon SS, et al.
-
l
- L-STEP
- Langer O, et al.
- LANTERN
- Larsson SC, et al.
- Lazarus G, et al.
- LEAD (4)
- LEADER (2)
- Lebovitz HE, et al.
- Lee JY, et al.
- Lee M, et al
- Li J, et al.
- Liakopoulos V, et al
- LIFE (6)
- Lin JJ, et al.
- Lind M, et al.
- LIPID
- LIPS
- Lipscombe LL, et al. (2)
- Lipska KJ, et al.
- Lira-1
- LIRA-SWITCH
- LISD
- Liu C, et al.
- Liverpool Diabetic Eye Study
- Logue J, et al.
- Lomonaco R, et al.
- Look AHEAD (14)
- Louisiana State University Hospital-Based Longitudinal Study
- Lu CH, et al.
- Ludvigsson J, et al.
- LUNA
- Lung TW, et al.
- Ly TT, et al.
-
m
- Maastricht Study
- Mainorino MI, et al.
- Malmo Preventive Trial
- Manson JE, et al.
- Manzella D, et al.
- Marbury T, et al.
- Marsico F, et al.
- Marso SP, et al.
- MARVAL
- Mathieu C, et al.
- Matthaei S, et al.
- Max MB, et al.
- MDC-CC (2)
- MDRD
- MDUTIS
- Medalist study
- MELANY
- Melidonis A, et al.
- MEMO study
- MERIT-HF
- MERLIN-TIMI 36
- MESA (2)
- MICRO-HOPE
- Microalbuminuria Captopril Study
- Microalbuminuria Collaborative Study
- MiG (2)
- Mimouni F, et al.
- MIRACL
- Mogensen UM, et al.
- Mohan V, et al.
- Monami M, et al. (3)
- Morgan CLI, et al. (2)
- MRC／BHF Heart Protection Study (2)
- MRFIT (5)
- Multicenter Insulin Lispro Study
- Multicenter Metformin Study
- Muraki I, et al.
- MUSASHI
-
n
- Nachum Z, et al. (2)
- NAFLD Database study
- Nagahama study
- Nagano Study
- Nakatani S, et al.
- Nauck M, et al.
- NAVIGATOR (3)
- Nazarzadeh M, et al. (2)
- NESTOR (2)
- Neuen BL, et al.
- NHANES
- NHIRD
- NHS (11)
- NHS/HPFS
- NHS/NHS II/HPFS (2)
- Nielsen SF and Nordestgaard BG
- NIPPON DATA90 (2)
- NOMAS
- North American Microalbuminuria Study
- North-East Italy Microalbuminuria Study
- Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium.
- Nyberg ST, et al.
-
-
p
- Palmer SC, et al.
- Pan A, et al.
- Papa G, et al.
- Pape GA, et al.
- Paprott R, et al.
- PARADIGM-HF
- Paris Prospective Study (3)
- Parveen R, et al.
- PATHWAY-3
- Pathways Study
- Patterson D, et al.
- PCAT-2
- PDHS
- PERISCOPE
- PERSUADE
- Peters SAE, et al.
- Pettersson B, et al.
- PHS (3)
- Pieber TR, et al.
- Pijls LT, et al.
- Pima Indians (4)
- PIONEER 1
- PIONEER 10
- PIONEER 2
- PIONEER 3
- PIONEER 4
- PIONEER 5
- PIONEER 6
- PIONEER 7
- PIONEER 8
- PIONEER 9
- PIONEER PLUS
- POPADAD
- PPP
- PREDIMED
- PREFER
- Preiss D.
- PREMIER
- PRESTO
- PREVEND
- Primary Prevention Trial Study
- PRIORITY
- PRISM-PLUS
- PRISMA
- PROactive (6)
- PROCAM
- PROSPECT
- PROVE IT-TIMI 22
- PSC/APCSC
-
q
- QUARTET
-
r
- RAVEL
- Ravid M, et al. (2)
- RCAV
- RECORD (4)
- Reed M, et al.
- Reichard P, et al.
- RENAAL (13)
- Renfrew and Paisley Survey
- Repaglinide Versus Nateglinide Comparison Study
- Repaglinide vs. Nateglinide Metformin Combination Study
- Repaglinide/Pioglitazone Study
- REPLACE-2
- REPLACE-BG Study
- RESULT
- REWIND (2)
- RIACE Italian Multicenter Study (2)
- RIAD
- Riccardi G, et al.
- RIO-Diabetes
- ROADMAP (2)
- Roche MM and Wang PP.
- Ronnemaa T, et al.
- Rosenstock J, et al. (2)
- Rotterdam Study (2)
- Roumie CL, et al.
-
s
- Sacks FM, et al.
- Saku study
- Sakurai M, et al.
- Salmeron J, et al.
- San Antonio Heart Study
- SANDS
- Sasaki A, et al. (6)
- SAVE (2)
- SAVOR-TIMI 53 (6)
- Sawatkar GU, et al.
- SCALE Insulin
- SCALE Obesity and Prediabetes study
- Scandinavian Repaglinide Group
- Schievink B, et al.
- Schnack C, et al.
- Schramm TK, et al.
- Schwabing Insulin Prophylaxis Pilot Trial
- Schwartz AV, et al.
- SDIS (2)
- SEARCH
- Seattle Diabetic Foot Study
- Seattle Japanese-American Community Diabetes Study
- Sebastiano Bruno Solerte, et al.
- SECURE
- Seino Y, et al. (2)
- Selby JV, et al.
- SENDCAP
- Seven Countries Study (3)
- Shan Z, et al.
- SHDS II
- SHEP (3)
- SHHS
- Shiba T, et al.
- Shimizu M, et al.
- SHOCK
- Shorr RI, et al.
- Shurraw S, et al.
- SIDESTEP
- Sildenafil Diabetes Study
- Simpson RW, et al.
- Singapore Longitudinal Aging Study
- Singh S, et al.
- SIRIUS
- Skupien J, et al.
- SMART
- SMILE
- SMOOTH
- Søfteland Ek, et al.
- SOLVD (2)
- Sorbinil Retinopathy Trial
- SOS (4)
- SPEAD-A
- SPIKE
- SPLINT
- SPREAD-DIMCAD
- SPRINT
- STAMPEDE
- STAR
- STAR 3
- STEADINESS
- Steno type 2 randomised study (2)
- Steno-2 study (2)
- STEP 6
- Stewart ZA, et al.
- STOP Hypertension-2
- STOP-NIDDM (4)
- Stracke H, et al.
- STRESS
- Strong Heart Study (4)
- Styrian Vitamin D Hypertension trial
- Suissa S, et al.
- Sun F, et al.
- SURPASS J-combo
- SURPASS J-mono
- SURPASS programme
- SURPASS-2
- SURPASS-4 (2)
- SURPASS-6
- SUSTAIN (11)
- Svanström H, et al.
- Svensson E, et al.
- Swedish Military Conscription Registry
- Swedish National Diabetes Register
- SWITCH 1
- SYNCHRONY
- Syst-China
- Syst-Eur (2)
-
t
- T1D Exchange Clinic Network (2)
- T1D Exchange Clinic Network Metformin RCT Study
- T1D Exchange Clinic Registry
- Tanabe M, et al.
- Tanaka K, et al.
- Tanno and Sobetsu study (2)
- TARGET
- Targher G, et al.
- TART
- TAXUS-IV
- TECOS (6)
- Tennant PW, et al.
- Thabit H, et al.
- Theilade S.
- THIN
- TIMAD
- TIMES 1
- TIMI
- TINSAL-T2D
- TNT (2)
- Tobias DK, et al. (2)
- Tokyo Study
- Tolrestat Study
- Toyota T, et al.
- TRACE
- TRANSCEND (2)
- TRAVEND
- TREAT
- Treat-to-Target study
- Treat-to-Target Trial
- Trevest K, et al.
- TRIAD (2)
- TRITON-TIMI 38
- Trocha AK, et al.
- Tsapas A, et al.
- Tseng CH, et al.
- Tseng YH, et al.
- Tsuda A, et al.
- Tsukuba Kawai Diabetes Registry
-
u
- Udell JA, et al.
- UGDP
- UK-based CPRD
- UKPDS (30)
- Uppsala Longitudinal Study of Adult Men
- Ushigome E, et al.
-
v
- VA Cooperative Study (2)
- VA NEPHRON-D study
- VA-HIT (2)
- VADT (3)
- VALIANT
- VALUE (2)
- van Bastelaar KM.
- van der Aart-van der Beek AB, et al.
- van Dijik M, et al.
- Vardarli I, et al.
- VARIATION
- VERIFY
- Verona Diabetes Complications Study
- VERTIS CV (3)
- VERTIS FACTORIAL
- VERTIS MET
- VERTIS MONO
- VHA
- Virtanen M, et al.
- VISS
- Voglibose Ph-3 Study
- Vupputuri S, et al.
-
w
- Wagner H, et al.
- Wan EYF, et al.
- Wang W, et al.
- Weber MA, et al.
- Weisman A, et al.
- Weng J, et al.
- WESDR (3)
- WHI
- WHI-OS
- Whitehall II Cohort Study
- Whitehall II study (3)
- Whitehall Study (3)
- Whitehall Survey
- WHO MSVDD (6)
- WHS
- Willemen MJ.
- WINGS-7
- WOSCOPS (2)
- WRAP
- Wu JHY, et al. (2)
- Wu JW, et al.
